Premier Asset Management LLC Astrazeneca PLC Transaction History

Premier Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $1.16 Million - $1.41 Million	-32,700 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$36.86 - $41.49 $89,385 - $100,613	2,425 Added 8.01%	32,700 $1.24 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $38,236 - $43,692	-1,100 Reduced 3.51%	30,275 $1.2 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $51,824 - $55,574	-1,500 Reduced 4.56%	31,375 $1.1 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $54,400 - $60,439	1,650 Added 5.28%	32,875 $1.15 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $4,813 - $5,217	-150 Reduced 0.48%	31,225 $1.08 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $908,620 - $1.07 Million	31,375	31,375 $1.06 Million

1,345

492M

4.99M

3.18M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.